首页> 美国政府科技报告 >External Open-Loop Pump for the Subcutaneous Infusion of Insulin in Diabetics
【24h】

External Open-Loop Pump for the Subcutaneous Infusion of Insulin in Diabetics

机译:外部开环泵用于糖尿病患者皮下输注胰岛素

获取原文

摘要

The preponderance of available information indicates that in some patients under controlled conditions, continuous subcutaneous insulin infusion (CSII) pumps are capable of reducing the blood glucose level of patients with insulin dependent diabetes mellitus (IDDM) to a near-normoglycemic state. Therapeutic trials of this device have been limited to carefully selected subjects afforded particularly close professional supervision. Available data do not demonstrate the superiority of CSII methods when compared with the results of equally intensive regimens using multiple manual insulin injections. The value of sustained normoglycemia in preventing diabetic complications also remains to be proven. The safety of insulin infusion pumps under routine conditions of widespread use among IDDM patients continues to be investigated. Questions remain concerning appropriate insulin preparations, therapeutic goals, and pump regimens. Until such information is available, CSII is considered to be investigational.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号